KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Cash from Operations: 2009-2025

Historic Cash from Operations for Charles River Laboratories International (CRL) over the last 17 years, with Sep 2025 value amounting to $213.8 million.

  • Charles River Laboratories International's Cash from Operations fell 15.08% to $213.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $749.5 million, marking a year-over-year decrease of 5.86%. This contributed to the annual value of $734.6 million for FY2024, which is 7.41% up from last year.
  • Per Charles River Laboratories International's latest filing, its Cash from Operations stood at $213.8 million for Q3 2025, which was up 4.51% from $204.6 million recorded in Q2 2025.
  • In the past 5 years, Charles River Laboratories International's Cash from Operations registered a high of $251.8 million during Q3 2024, and its lowest value of $102.6 million during Q1 2022.
  • Moreover, its 3-year median value for Cash from Operations was $193.5 million (2024), whereas its average is $182.6 million.
  • As far as peak fluctuations go, Charles River Laboratories International's Cash from Operations surged by 148.18% in 2021, and later slumped by 39.71% in 2022.
  • Quarterly analysis of 5 years shows Charles River Laboratories International's Cash from Operations stood at $229.3 million in 2021, then rose by 2.40% to $234.8 million in 2022, then declined by 5.88% to $220.9 million in 2023, then fell by 27.87% to $159.4 million in 2024, then fell by 15.08% to $213.8 million in 2025.
  • Its last three reported values are $213.8 million in Q3 2025, $204.6 million for Q2 2025, and $171.7 million during Q1 2025.